Abstract
Introduction: There are currently no data on the use of the wearable cardioverter defibrillator (WCD) in left ventricular assist device (LVAD) patients for the protection from sudden cardiac death (SCD). We aimed to review data available on the use of the WCD in LVAD patients. Methods: The WCD Medical Order Registry was screened for patients with implanted LVAD at the time of WCD use. Indication for WCD use in this cohort, compliance data, arrhythmia events, and end of use decision are reported. Conclusions: In this first clinical experience of the WCD in LVAD patients, WCD use was feasible in the majority of the patients. WCD might be an alternative for temporary monitoring and protection from SCD in LVAD patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
